Titan Pharmaceuticals Names Dato' Seow Gim Shen As Chairman Of The Board; Adds Brynner Chaim To Board; David Lazar And Peter Chasey Resign From Board
Portfolio Pulse from Benzinga Newsdesk
Titan Pharmaceuticals has announced changes to its board of directors. Dato' Seow Gim Shen has been appointed as the new Chairman, while Brynner Chaim has been added to the board. David Lazar and Peter Chasey have resigned from the board, but Lazar will continue to serve as the company's CEO.
October 16, 2023 | 8:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The board changes at Titan Pharmaceuticals could potentially impact the company's strategic direction. The new Chairman and board member could bring fresh perspectives, while the continuity of David Lazar as CEO ensures stability.
Board changes can often lead to shifts in company strategy, which could impact the company's performance and, by extension, its stock price. However, the impact of these changes is uncertain in the short term, hence the neutral score.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100